GW&K Investment Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1082917
BOSTON, MA
Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$78,217,331
-$3,568,654 QoQ
Shares Held
593,725
+3.0% QoQ
Ownership
0.590%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.79717040717503.ToString("F0")%
Shared 7.164764832203462.ToString("F0")%
None 0.038064760621499855.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $163,730,959 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (47.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
593,725 | $78,217,331 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,055,184 | $54,542,460 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,240,462 | $30,849,197 | |
| 4 | VTRS |
Viatris Inc
|
2,967 | $40,084 | |
| 5 | HLN |
Haleon plc
|
3,869 | $38,728 | |
| 6 | ZTS |
Zoetis Inc.
|
208 | $24,587 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
580 | $10,741 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
260 | $7,831 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,217,331 | 593,725 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $81,785,985 | 576,648 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $83,439,766 | 594,385 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $76,968,156 | 612,365 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $56,555,972 | 511,356 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $70,172,192 | 514,082 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $58,772,453 | 510,089 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $75,177,181 | 546,068 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $72,804,381 | 527,874 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $70,618,352 | 535,962 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $62,413,987 | 554,791 | Shares | Other | 2023-11-09 | |
| 2023-06-30 | $54,123,956 | 573,955 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $58,788,272 | 580,797 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $68,623,296 | 574,542 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $63,229,786 | 595,328 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $60,136,289 | 616,909 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $63,697,405 | 679,439 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $39,060,239 | 458,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $42,572,721 | 443,882 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $43,731,520 | 449,358 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $42,885,499 | 440,982 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $37,121,075 | 387,283 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $37,416,144 | 389,103 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $45,989,852 | 376,966 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $32,342,349 | 373,684 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||